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Abstract 
The recent outbreaks of diseases including Ebola reemergence in the Democratic Republic of Congo (DRC), Nipah virus outbreak in India, Lassa virus 
in Nigeria and the continued Influenza pandemic show that we cannot predict outbreaks, however, developing response plans could help alleviate 
the burden of diseases. Developing response plans involves strategies such as creating a repository of microbial agents as well as the implementation 
of the plans. In addition, zoonotic experts and policy makers should work together in order to succeed in fighting against any disease outbreaks. We 
should also not forget about the importance of vaccination because of the benefits it has brought to humankind preventing disease occurrence. 
Furthermore, the challenges that come with vaccination including vaccine delivery and vaccine uptake need to be overcome to make sure that this 
public health tool continues to be effective. Overcoming these vaccination challenges would play a significant role in decreasing the overuse of 
antimicrobials, hence avoiding resistance. The One Health Community (OHC) therefore has the responsibility to advocate for the use of vaccines and 
show that it has costs benefits; this strategy has the potential to fight against antimicrobial resistance. 
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The fifth International One Health Congress was held in Saskatoon, 
Canada and was tailored towards discussing the threats of emerging 
and reemerging diseases, addressing the challenges the world faces 
concerning antimicrobial resistance and bridging the gap between 
zoonotic experts and policy makers in the field of disaster risk 
reduction. Regarding emerging and reemerging diseases, there was 
a discussion on four major disease recent outbreaks including Ebola 
reemergence in the Democratic Republic of Congo (DRC) [1], Nipah 
virus outbreak in India [2], Lassa virus in Nigeria [3] and the 
continued Influenza pandemic [4]. With regards to the emerging and 
reemerging diseases, the question that was posed was: can we 
predict major disease outbreaks? It was clear from the reemergence 
of those outbreaks that we are not able to predict major disease 
outbreaks. Therefore, since we are not able to predict those 
epidemics, we can prepare in advance to counter the emergence of 
diseases by developing preparedness or response plans which will 
assist in managing and preempting the spread of the specific disease. 
Furthermore, there was a discussion about the benefits and 
challenges of vaccination and these challenges include barriers to 
vaccine delivery and vaccine uptake. Concerning antimicrobial 
resistance, individuals tend to use these agents to cure diseases. This 
has the potential to cause resistance and various strategies are thus 





"We are not able to predict major disease outbreaks" 
  
The recent disease epidemics (Ebola, Nipah virus, Lassa virus and 
continued flu epidemic) are a clear indication that we cannot predict 
major disease outbreaks. The Ebola Virus Disease (EVD) was first 
discovered in 1976 near the Ebola River in the DRC. EVD is classified 
as a zoonotic disease since it emanates from animals and then passed 
on to people. This disease is common in the DRC with the current 
outbreak being the ninth one. The Ebola epidemic was recently 
detected on the 8th of May 2018 and up to the 6th of July, there has 
been a total of 53 Ebola cases with 38 confirmed and 15 probable 
cases, that is, the suspected cases that died without having been 
confirmed in the laboratory [5]. The Nipah virus outbreak in India is 
another example that diseases can emerge without having been 
predicted. This virus has so far claimed 17 lives, with one person 
having survived the disease. There is no known vaccine or therapy to 
treat or prevent Nipah, therefore, healthcare workers use supportive 
treatment while the immune system tries to fight against this 
virus [2]. 
  
Another disease outbreak, that is, Lassa fever, was detected in 19 
states of Nigeria in January 2018 where it claimed 107 lives from 423 
confirmed cases. In addition, 27 healthcare workers have been 
infected and eight have died. As for influenza, its detection continues 
to rise in the Southern part of the African continent and in other 
countries such as Australia and New Zealand. The WHO laboratories 
have isolated more than 52621 suspected cases of flu, of which 1376 
were confirmed positive for influenza virus. Of these positive cases, 
1047 were type A and 329 type B influenza. Since the disease 
outbreaks cannot be detected, response plans need to be developed 
and implemented when these outbreaks occur [6]. We are not able 
to detect major disease outbreaks, however, we can prepare in 
advance to counter the emergence of diseases. Preparing for the 
emergence of diseases include developing preparedness or response 
plans, by, for example, creating a repository of microbial agents, 
conducting a functional analysis of virus families causing diseases like 
flu and implementing the pandemic plans [6]. Furthermore, bridging 
the gap between zoonotic experts and policy makers is one of the 
very important strategies to consider if we are to win the fight against 
a certain disease epidemic. We should also not forget the benefits 
vaccination has brought to humankind as far as fighting infections is 
concerned [7]. 
  
As per the discussions in the OHC, veterinary vaccines are also very 
important to develop in order to prevent disease transmission from 
animals to humans. Vaccination, has, in the past, prevented and 
fought diseases like smallpox, polio, measles, and whooping cough. 
Therefore, it is important for experts to always emphasize the 
importance of vaccination and the consequences that come with 
choosing not to vaccinate [7]. This implies that the One Health 
Community should be committed to enthusiastically communicate 
about the need for individuals to vaccinate. 
  
Challenges around vaccination 
  
Although vaccination is a worldwide tool used to prevent diseases, 
there are still challenges around it. These include barriers to vaccine 
delivery, e.g. cold chain issues and lack of trained staff and poor 
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healthcare infrastructure. Cold chain issues may involve, storage 
activities (interrupted refrigeration), cold packaging and distribution 
factors. On the other hand, lack of trained staff and poor healthcare 
infrastructure are major barriers that could decrease vaccination 
coverage tremendously if attention is not paid towards fixing such 
problems [8]. 
  
Other barriers include those pertaining to vaccine uptake, e.g. 
affordability, trust of healthcare providers and sociocultural factors. 
Although the cost of vaccines per child has increased, the cost-
effectiveness of immunization in low and middle-income countries has 
made vaccines easily accessible and hence has contributed towards 
increased coverage rates. Another important factor that determines 
vaccine uptake is the manner in which healthcare providers present 
themselves and communicate about vaccines. There tends to be some 
resistance towards taking vaccines if the recipient does not trust or 
believe in the provider. Regarding sociocultural issues, the lack of 
understanding on what has caused the disease and also religious and 
social restrictions enforced by religious and community leaders on 




Antimicrobial resistance (AMR) is the capability of microorganisms, 
e.g. bacteria, viruses and some parasites, to stop antimicrobials (e.g. 
antibiotics, antivirals and antimalarials) from working against that 
particular pathogen [10]. There generally has been an emphasis or 
focus on promoting antimicrobials, e.g., by making them less costly. 
This implies that people will tend to use these agents to cure diseases. 
This can lead to the overuse of antimicrobials which can cause 
resistance; therefore, various strategies are necessary in order to 
overcome this problem. These strategies include pushing for the use 
of vaccines by demonstrating the cost benefits of both animal and 
human vaccines and addressing high costs in low and middle-income 
countries [11]. These strategies would encourage or lead to the use 
of vaccines to prevent disease occurrences and possibly also decrease 





The recent emergence of the diseases in the various countries 
clearly shows that we cannot predict outbreaks, however, 
developing preparedness or response plans could play a significant 
role in managing and controlling the spread of disease. Developing 
response plans does not only involve strategies such as creating a 
repository of microbial agents, conducting a functional analysis of 
virus families causing diseases but should also include 
implementing the pandemic plans in order to successfully fight 
against the disease outbreaks. In addition to developing response 
plans, there should be a bridge between zoonotic experts and policy 
makers to successfully fight against emerging diseases. We should 
also support the use of vaccination because of the benefits it has 
brought to humankind as far as fighting infections is concerned. 
Although vaccination is a significant public health tool used to 
prevent diseases, it has several challenges which include vaccine 
delivery (e.g. cold chain issues) and vaccine uptake (e.g. 
affordability, trust of healthcare providers and sociocultural issues). 
It is very important to work towards overcoming these vaccination 
challenges as promoting the use of vaccines has the potential to 
help fight against antimicrobial resistance. The overuse of 
antimicrobials can lead to resistance; therefore, the One Health 
Community can show that vaccination has cost benefits; this is one 
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